巨噬细胞移动抑制因子（MIF）是一种潜在的促炎细胞因子，是天然免疫和获得性免疫中的关键调节元件。
Macrophage migration inhibitory factor(MIF), a potential pro inflammatory cytokine, is a pivotal regulatory element in the nature and adapted immune.
目的观察妇科恶性肿瘤患者血清、腹腔液中巨噬细胞移动抑制因子(MIF)的表达及其与恶性肿瘤的相关性。
Objective to investigate the expressions of macrophage migration inhibitory factor (MIF) in gynecologic malignancy tumor patients and the correlation between VEGF and CA125.
抑制巨噬细胞炎性细胞因子的分泌有助于治疗动脉粥样硬化及其临床并发症。
Inhibiting the secretion of macrophage inflammatory cytokine is good for healing atherosclerosis and its clinical complications.
应用推荐